Secondary neoplasms after stereotactic radiosurgery
Related Experiment Video
Updated: May 6, 2026
Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
Published on: June 7, 2015
Toral R Patel1, Veronica L S Chiang1
1Department of Neurosurgery, Yale University School of Medicine, New Haven, Connecticut, USA.
Objective:
The use of medical radiation has increased 6-fold in the past 30 years. Within neurosurgery, the advent of stereotactic radiosurgery (SRS) has significantly altered the treatment paradigm for both benign and malignant central nervous system diseases. With this increased reliance on radiation has come a responsibility to identify the long-term risks, including the potential development of radiation-induced neoplasms. Although the data regarding traditional radiation exposure and its subsequent risks are well-defined, the data for SRS is less developed.
Methods:
We reviewed the published literature to more accurately define the risk of developing secondary neoplasms after stereotactic radiosurgery.
Results:
A total of 36 cases of SRS-induced neoplasms were identified. More than half of the cases had an initial diagnosis of vestibular schwannoma. Overall, the risk of developing an SRS-induced neoplasm is approximately 0.04% at 15 years.
Conclusion:
The risk of developing an SRS-induced neoplasm is low but not zero. Thus, long-term surveillance imaging is advised for patients treated with SRS.
